|
Ramachandran, C; Kunikane, H; You, W et al. (1998) Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochem Pharmacol 56:709-18
|
|
Ramachandran, C; You, W; Krishan, A (1997) Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells. Anticancer Res 17:3369-76
|
|
Mou, C; Ganju, N; Sridhar, K S et al. (1997) Simultaneous quantitation of plasma doxorubicin and prochlorperazine content by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 703:217-24
|
|
Krishan, A; Fitz, C M; Andritsch, I (1997) Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279-85
|
|
Kunikane, H; Zalupski, M M; Ramachandran, C et al. (1997) Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas. Cytometry 30:197-203
|
|
Ramachandran, C; Mead, D; Wellham, L L et al. (1995) Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse. Biochem Pharmacol 49:545-52
|
|
Isobe, H; Sridhar, K S; Doria, R et al. (1995) Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma. Cytometry 19:86-91
|
|
Isobe, H; Wellham, L; Sauerteig, A et al. (1994) Doxorubicin retention and chemoresistance in human mesothelioma cell lines. Int J Cancer 57:581-5
|
|
Sridhar, K S; Krishan, A; Samy, T S et al. (1994) Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker. Cancer Chemother Pharmacol 34:377-84
|
|
Ramachandran, C; Samy, T S; Huang, X L et al. (1993) Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells. Biochem Pharmacol 45:1367-71
|
Showing the most recent 10 out of 22 publications
